Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Lambert

Showing results (21-30 of 164) with videos related to

Pageof 17
Sort By:
Journal of Lipid Research|September 28, 2005
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient miceElyisha A Hanniman, Gilles Lambert, Tanya C McCarthy, et al.
British Journal of Haematology|February 18, 2026
Transfusion reactions reported to the Québec haemovigilance system between 2005 and 2022: A comparison of paediatric and adult recipientsNancy Robitaille, Samuel Rochette, Karl Itaj Nawej, et al.
Atherosclerosis|December 3, 2010
Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24h insulin infusion in healthy subjects and type 2 diabetic patientsPaul J W H Kappelle, Gilles Lambert, Robin P F Dullaart
Pharmacology & Therapeutics|July 22, 2014
PCSK9 inhibition in LDL cholesterol reduction: genetics and therapeutic implications of very low plasma lipoprotein levelsA David Marais, Jae B Kim, Scott M Wasserman, et al.
Journal of Lipid Research|August 16, 2023
PCSK9 and the nervous system: a no-brainer?Ali K Jaafar, Romuald Techer, Kévin Chemello, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2010
Beyond LDL cholesterol, a new role for PCSK9Omar N Akram, Adeline Bernier, Francine Petrides, et al.
Transfusion|October 31, 2014
Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance SystemJoy Benadiba, Nancy Robitaille, Gilles Lambert, et al.
Current Atherosclerosis Reports|March 31, 2022
Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E IsoformsKévin Chemello, Dirk J Blom, A David Marais, et al.
The Journal of Biological Chemistry|August 5, 2004
Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosisYusuke Inoue, Junko Inoue, Gilles Lambert, et al.
Current Opinion in Lipidology|July 3, 2013
The promises of PCSK9 inhibitionFrancine Petrides, Kate Shearston, Mathias Chatelais, et al.
Pageof 17

Showing results (21-30 of 164) with videos related to

Sort By:
Pageof 17
Journal of Lipid Research|September 28, 2005
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient miceElyisha A Hanniman, Gilles Lambert, Tanya C McCarthy, et al.
British Journal of Haematology|February 18, 2026
Transfusion reactions reported to the Québec haemovigilance system between 2005 and 2022: A comparison of paediatric and adult recipientsNancy Robitaille, Samuel Rochette, Karl Itaj Nawej, et al.
Atherosclerosis|December 3, 2010
Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24h insulin infusion in healthy subjects and type 2 diabetic patientsPaul J W H Kappelle, Gilles Lambert, Robin P F Dullaart
Pharmacology & Therapeutics|July 22, 2014
PCSK9 inhibition in LDL cholesterol reduction: genetics and therapeutic implications of very low plasma lipoprotein levelsA David Marais, Jae B Kim, Scott M Wasserman, et al.
Journal of Lipid Research|August 16, 2023
PCSK9 and the nervous system: a no-brainer?Ali K Jaafar, Romuald Techer, Kévin Chemello, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2010
Beyond LDL cholesterol, a new role for PCSK9Omar N Akram, Adeline Bernier, Francine Petrides, et al.
Transfusion|October 31, 2014
Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance SystemJoy Benadiba, Nancy Robitaille, Gilles Lambert, et al.
Current Atherosclerosis Reports|March 31, 2022
Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E IsoformsKévin Chemello, Dirk J Blom, A David Marais, et al.
The Journal of Biological Chemistry|August 5, 2004
Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosisYusuke Inoue, Junko Inoue, Gilles Lambert, et al.
Current Opinion in Lipidology|July 3, 2013
The promises of PCSK9 inhibitionFrancine Petrides, Kate Shearston, Mathias Chatelais, et al.
Pageof 17